ABOS Acumen Pharmaceuticals, Inc.
Nasdaq · SEC CIK 1576885 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $625.6K 21 sales by 9 insiders
- Filings on record
- 120 since 2021-07-02, latest 2026-06-17 17:10
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Meisner Derek M | CLO, Corp Sec | — | $248.8K |
| OConnell Daniel Joseph | CEO, Dir | — | $163.2K |
| Porter Derrell | Dir | — | $75.2K |
| Zuga Matt | CFO, Chief Business Off | — | $49.6K |
| Barton Russell | COO | — | $30.0K |
| Siemers Eric | Chief Medical Off | — | $27.1K |
| Doherty James J. | Pres, CDO | — | $15.2K |
| Fountain Nathan B | Dir | — | $14.3K |
| Schacterle Amy | Chief Regulatory Off | — | $2,172 |
| Stoppel Laura | Dir | — | — |
Transactions 103
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-08 | 2021-07-06 | ABOS | Zuga Matt | CFO | C - Cnv Deriv | — | +26.2K | 26.2K | New | — |
| DMI | 2021-07-08 | 2021-07-06 | ABOS | Manning Paul B | 10% | C - Cnv Deriv | — | +3.61M | 658.0K | New | — |
| DI | 2021-07-08 | 2021-07-06 | ABOS | Manning Paul B | 10% | P - Purchase | $16.00 | +312.5K | 3.35M | +10% | +$5.00M |
Purchase Sale Sale after option exercise All abbreviations